Stem Cells Heal Intestinal Disease in Premature Infants by Colleen Fleiss on May 1, 2021 at 1:16 AM A human placental-derived stem cell (hPSC) therapy strategy is found to treat necrotizing enterocolitis (intestinal bowel disease) that affects up to 10 percent of premature infants. The intestinal bowel disease is at a very vulnerable and developmentally crucial time can lead to serious infection and death. The cause of necrotizing enterocolitis is unclear - it is a multi-faceted disease that results from the complex interaction of early bacterial colonization, an exaggera...